Prevalence of inducible clindamycin resistance in macrolide-resistant Staphylococcus spp

Clinical Microbiology and Infection

Volumn 11, Issue 4, 2005, Pages 337-340

  Fokas, S ^a   Tsironi, M ^a   Kalkani, M ^a   Dionysopouloy, M ^a  

^a Department of Internal Medicine   (Greece)

Author keywords

Clindamycin resistance; Coagulase negative staphylococci; Macrolide resistance; Resistance; Staphylococcus; Susceptibility testing

Indexed keywords

CLINDAMYCIN; MACROLIDE; METICILLIN; OXACILLIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; COAGULASE NEGATIVE STAPHYLOCOCCUS; GREECE; HOSPITAL; HUMAN; NONHUMAN; PHENOTYPIC VARIATION; PREVALENCE; PRIORITY JOURNAL; SCREENING; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS HAEMOLYTICUS; STAPHYLOCOCCUS HOMINIS; STAPHYLOCOCCUS LUGDUNENSIS; STAPHYLOCOCCUS SAPROPHYTICUS;

STAPHYLOCOCCI; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS;

EID: 15944426803     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2005.01101.x     Document Type: Article

References (15)

1. Leclercq R, Courvalin P. Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification. Antimicrob Agents Chemother 1991; 35: 1265-1272.
2. Ross JI, Eady EA, Cove JH, Cunliffe WJ, Baumberg S, Wootton JC. Inducible erythromycin resistance in staphylococci is encoded by a member of the ATP-binding transport super-gene family. Mol Microbiol 1990; 4: 1207-1214.
3. Prunier AL, Malbruny B, Tandé D, Picard B, Leclercq R. Clinical isolates of Staphylococcus aureus with ribosomal mutations conferring resistance to macrolides. Antimicrob Agents Chemother 2002; 46: 3054-3056.
4. Wondrack L, Massa M, Yang BV, Sutcliffe J. Clinical strain of Staphylococcus aureus inactivates and causes efflux of macrolides. Antimicrob Agents Chemother 1996; 40: 992-998.
5. Weisblum B, Demohn V. Erythromycin-inducible resistance in Staphylococcus aureus: survey of antibiotic classes involved. J Bacteriol 1969; 98: 447-452.
6. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing, 12th informational supplement. Approved standard M2-A7. Wayne, PA: NCCLS, 2002.
7. Jenssen WD, Thakker-Varia S, Dublin DT, Weinstein MP. Prevalence of macrolide-lincosamide-streptogramin B resistance and erm gene classes among clinical strains of staphylococci and streptococci. Antimicrob Agents Chemother 1987; 31: 883-888.
8. Fiebelkorn KR, Crawford SA, McElmeel ML, Jorgensen JH. Practical disk diffusion method for detection of inducible clindamycin resistance in Staphylococcus aureus and coagulase-negative staphylococci. J Clin Microbiol 2003; 41: 4740-4744.
9. Schmitz FJ, Sadurski R, Kray A et al. Prevalence of macrolide-resistance genes in Staphylococcus aureus and Enterococcus faecium isolates from 24 European university hospitals. J Antimicrob Chemother 2000; 45: 891-894.
10. Lina G, Quaglia A, Reverdy ME, Leclercq R, Vandenesch F, Etienne J. Distribution of genes encoding resistance to macrolides, lincosamides, and streptogramins among staphylococci. Antimicrob Agents Chemother 1999; 43: 1062-1066.
11. Melter O, Aires de Sous M, Urbaskova P, Jakubu V, Zemliskova H, Lencastre H. Update on the major clonal types of methicillin-resistant Staphylococcus aureus in the Czech Republic. J Clin Microbiol 2003; 41: 4998-5005.
12. Panagea S, Perry JD, Gould FK. Should clindamycin be used in treatment of patients with infections caused by erythromycin-resistant staphylococci? J Antimicrob Chemother 1999; 44: 581-582.
13. Drinkovic D, Fuller ER, Shore KP, Holland DJ, Ellis-Pegler R. Clindamycin treatment of Staphylococcus aureus expressing inducible clindamycin resistance. J Antimicrob Chemother 2001; 48: 315-316.
14. Siberry G, Tekle T, Carroll K, Dick J. Failure of clindamycin treatment of methicillin-resistant Staphylococcus aureus expressing inducible clindamycin resistance in vitro. Clin Infect Dis 2003; 37: 1257-1260.
15. Gopal Rao G. Should clindamycin be used in treatment of patients with infections caused by erythromycin-resistant staphylococci? J Antimicrob Chemother 2000; 45: 715-716.